TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,781,803
|
2,697,602
|
2,580,396 |
| Financial expenses |
7,285
|
16,824
|
10,420 |
| Earnings before taxes |
191,279
|
208,813
|
158,631 |
| EBITDA |
189,648
|
220,511
|
170,121 |
| Total assets |
903,676
|
838,494
|
853,676 |
| Current assets |
885,681
|
821,419
|
836,862 |
| Current liabilities |
176,556
|
246,829
|
307,012 |
| Equity capital |
644,616
|
510,623
|
419,344 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
22
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
71.3%
|
60.9%
|
49.1% |
| Turnover per employee |
80,991
|
112,400
|
122,876 |
| Profit as a percentage of turnover |
10.7%
|
7.7%
|
6.1% |
| Return on assets (ROA) |
22.0%
|
26.9%
|
19.8% |
| Current ratio |
501.6%
|
332.8%
|
272.6% |
| Return on equity (ROE) |
29.7%
|
40.9%
|
37.8% |
| Change turnover |
-964,440
|
-65,891
|
213,774 |
| Change turnover % |
-35%
|
-2%
|
9% |
| Chg. No. of employees |
-2
|
3
|
0 |
| Chg. No. of employees % |
-8%
|
14%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.